Optimal use of atypical antipsychotics for schizophrenia combination therapy, high doses, and clozapine -- current practice study
The objective of this study was to explore the views and experiences of health care professionals with respect to the use of atypical antipsychotic (AAP) combination therapy and high-dose treatment strategies in adolescents and adults with schizophrenia
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
August 2012, 2012
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this study was to explore the views and experiences of health care professionals with respect to the use of atypical antipsychotic (AAP) combination therapy and high-dose treatment strategies in adolescents and adults with schizophrenia |
|---|---|
| Item Description: | "This report was prepared by the Canadian Agency for Drugs and Technologies in Health (CADTH)"--T.p. verso |
| Physical Description: | 1 PDF file (i, 42 pages) |